A Practical Process for Obtaining Reimbursement
We don't just plan strategies—we execute the path to payment. Our process bridges the "Valley of Death" between regulatory clearance and actual revenue. We ensure your medical device or drug is not just "market-ready," but market-funded across US and European healthcare systems.
| Activity | Description | Phase | May Impact |
|---|---|---|---|
|
1. Reimbursement Landscape
|
a. Money flows and financial incentives
b. Reimbursement mechanisms
c. Decision makers and strategy
|
R&D |
Features and applications
Predicate device / intended use
Price
|
|
2. Reimbursement Planning
|
a. Value story
b. Economic model
c. Support of clinical data
d. Feedback from decision makers
|
Pre Clinical |
Clinical study protocol
Business case
Market size
|
|
3. Obtaining Reimbursement (Implementation)
|
a. Billing guides and Dossier submission
b. Securing local medical community support
c. Prior authorizations and denial appeals
d. Direct negotiations and pilot projects with payers
e. Establishing new reimbursement mechanisms (NUB, Liste en Sus)
|
Pre-Sales & Launch |
Time to Revenue
Cash Flow Sustainability
Exit Valuation
|